All In MedTech

Device Trial Radar · NCT07276529

Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses

Safety and Device Functionality of the Flexagon Self Forming Magnet Anastomosis Plus OTOLoc for Creating Ileo-colic, Colo-colonic and Colorectal Anastomoses in Patients Undergoing Surgical Procedures

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Apr 1, 2026

Primary completion

Jun 2027

Study completion Jul 2027

Sponsor

Lead sponsor
GI Windows, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Dec 11, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this trial is to investigate the safety and effectiveness of the Flexagon 25mm SFM system plus OTOLoc when used to create a side-to-side Ileo-colic, Colo-colonic and side-to-side or end-to-side colorectal anastomoses in participants undergoing colon surgery. This will be evaluated via a composite safety/effectiveness endpoint of patient success defined as successful creation of the target anastomosis without placement procedure, device or target anastomosis related reoperation through 30 days.

Conditions

  • Colorectal Cancer
  • Diverticular Diseases

Interventions

  • Flexagon Self Forming Magnet Anastomosis Plus OTOLoc for Creating side-to-side Colon AnatomosesDevice

    The SFM plus OTOLoc is used to create an immediate flow compression anastomosis for patients undergoing: Right or Left Hemicolectomy, Sigmoidectomy and Low Anterior resection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Successful anastomosis created with the Flexagon SFM plus OTOLoc without reoperation.Time frame: 30 days
  2. Anastomosis successTime frame: 30 days

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Orlando Health

    Orlando, Florida · Recruiting

  • University of Texas Health Science Center

    Houston, Texas · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.